Theralase Technologies Inc. (CVE:TLT – Get Free Report) shot up 2.4% on Friday . The stock traded as high as C$0.21 and last traded at C$0.21. 63,000 shares changed hands during trading, a decline of 35% from the average session volume of 97,553 shares. The stock had previously closed at C$0.21.
Theralase Technologies Trading Up 2.4%
The stock has a market cap of C$53.98 million, a P/E ratio of -11.67 and a beta of -0.23. The company has a current ratio of 1.91, a quick ratio of 3.40 and a debt-to-equity ratio of 14.85. The company has a 50-day moving average price of C$0.20 and a two-hundred day moving average price of C$0.20.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
See Also
- Five stocks we like better than Theralase Technologies
- With Risk Tolerance, One Size Does Not Fit All
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- What is a penny stock? A comprehensive guide
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
